The discovery of threosyl phosphonate nucleoside (PMDTA, EC₅₀ = 2.53 μM) as a potent anti-HIV agent has led to the synthesis and biological evaluation of 5 '-deoxyversions of threosyl phosphonate nucleosides from 1,4-dihydroxy-2-butene. The synthesized nucleoside phosphonic acid analogues 14 and 19 were tested for anti-HIV activity as well as cytotoxicity. The adenine analogue 14 exhibits moderate in vitro anti-HIV-1 activity (EC₅₀ = 12.6 μM).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/15257770.2012.670349 | DOI Listing |
Publication Analysis
Top Keywords
potent anti-hiv
8
threosyl phosphonate
8
design synthesis
4
synthesis novel
4
novel threosyl-5'-
4
threosyl-5'- deoxyphosphonic
4
deoxyphosphonic acid
4
acid purine
4
purine analogues
4
analogues potent
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!